Zhongzhu Medical Holdings Co Ltd (600568) - Net Assets
Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has net assets worth CN¥1.61 Billion CNY (≈ $235.40 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.95 Billion ≈ $285.43 Million USD) and total liabilities (CN¥341.90 Million ≈ $50.03 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 600568 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.61 Billion |
| % of Total Assets | 82.47% |
| Annual Growth Rate | 13.1% |
| 5-Year Change | -56.26% |
| 10-Year Change | -72.88% |
| Growth Volatility | 85.84 |
Zhongzhu Medical Holdings Co Ltd - Net Assets Trend (1998–2025)
This chart illustrates how Zhongzhu Medical Holdings Co Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Zhongzhu Medical Holdings Co Ltd to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Zhongzhu Medical Holdings Co Ltd (1998–2025)
The table below shows the annual net assets of Zhongzhu Medical Holdings Co Ltd from 1998 to 2025. For live valuation and market cap data, see Zhongzhu Medical Holdings Co Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.63 Billion ≈ $238.63 Million |
-6.43% |
| 2024-12-31 | CN¥1.74 Billion ≈ $255.02 Million |
-32.72% |
| 2023-12-31 | CN¥2.59 Billion ≈ $379.07 Million |
-11.79% |
| 2022-12-31 | CN¥2.94 Billion ≈ $429.73 Million |
-21.24% |
| 2021-12-31 | CN¥3.73 Billion ≈ $545.62 Million |
-6.31% |
| 2020-12-31 | CN¥3.98 Billion ≈ $582.38 Million |
+2.26% |
| 2019-12-31 | CN¥3.89 Billion ≈ $569.54 Million |
-8.57% |
| 2018-12-31 | CN¥4.26 Billion ≈ $622.92 Million |
-30.74% |
| 2017-12-31 | CN¥6.15 Billion ≈ $899.41 Million |
+2.23% |
| 2016-12-31 | CN¥6.01 Billion ≈ $879.82 Million |
+127.31% |
| 2015-12-31 | CN¥2.65 Billion ≈ $387.06 Million |
+2.54% |
| 2014-12-31 | CN¥2.58 Billion ≈ $377.47 Million |
+118.82% |
| 2013-12-31 | CN¥1.18 Billion ≈ $172.51 Million |
+14.70% |
| 2012-12-31 | CN¥1.03 Billion ≈ $150.39 Million |
+12.22% |
| 2011-12-31 | CN¥915.88 Million ≈ $134.02 Million |
+23.31% |
| 2010-12-31 | CN¥742.77 Million ≈ $108.69 Million |
+9.67% |
| 2009-12-31 | CN¥677.27 Million ≈ $99.11 Million |
+9.90% |
| 2008-12-31 | CN¥616.24 Million ≈ $90.17 Million |
+19.66% |
| 2007-12-31 | CN¥514.98 Million ≈ $75.36 Million |
+7.46% |
| 2006-12-31 | CN¥479.24 Million ≈ $70.13 Million |
-14.23% |
| 2005-12-31 | CN¥558.76 Million ≈ $81.76 Million |
+14.15% |
| 2004-12-31 | CN¥489.48 Million ≈ $71.63 Million |
+3.50% |
| 2003-12-31 | CN¥472.91 Million ≈ $69.20 Million |
+6.35% |
| 2002-12-31 | CN¥444.66 Million ≈ $65.07 Million |
+2.58% |
| 2001-12-31 | CN¥433.47 Million ≈ $63.43 Million |
+426.29% |
| 2000-12-31 | CN¥82.36 Million ≈ $12.05 Million |
+18.07% |
| 1999-12-31 | CN¥69.76 Million ≈ $10.21 Million |
+18.87% |
| 1998-12-31 | CN¥58.68 Million ≈ $8.59 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhongzhu Medical Holdings Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24881.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥5.02 Billion | 306.55% |
| Total Equity | CN¥1.64 Billion | 100.00% |
Zhongzhu Medical Holdings Co Ltd Competitors by Market Cap
The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cannae Holdings Inc
NYSE:CNNE
|
$691.40 Million |
|
Shengtak New Material Co Ltd
SHE:300881
|
$691.66 Million |
|
Shenzhen Refond Optoelectronics Co Ltd
SHE:300241
|
$691.68 Million |
|
Suprajit Engineering Limited
NSE:SUPRAJIT
|
$692.11 Million |
|
HDC Holdings Co Ltd
KO:012630
|
$691.06 Million |
|
McCormick & Company Incorporated
NYSE:MKC-V
|
$690.96 Million |
|
GuangDong Rifeng Electric Cable Co Ltd
SHE:002953
|
$690.56 Million |
|
Grendene S.A
SA:GRND3
|
$690.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhongzhu Medical Holdings Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,749,275,473 to 1,636,000,631, a change of -113,274,842 (-6.5%).
- Net loss of 114,191,647 reduced equity.
- Dividend payments of 32,959 reduced retained earnings.
- Other comprehensive income decreased equity by 122,563,202.
- Other factors increased equity by 123,512,966.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-114.19 Million | -6.98% |
| Dividends Paid | CN¥32.96K | -0.0% |
| Other Comprehensive Income | CN¥-122.56 Million | -7.49% |
| Other Changes | CN¥123.51 Million | +7.55% |
| Total Change | CN¥- | -6.48% |
Book Value vs Market Value Analysis
This analysis compares Zhongzhu Medical Holdings Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.89x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 29.32x to 2.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | CN¥0.08 | CN¥2.37 | x |
| 1999-12-31 | CN¥0.10 | CN¥2.37 | x |
| 2000-12-31 | CN¥0.11 | CN¥2.37 | x |
| 2001-12-31 | CN¥0.60 | CN¥2.37 | x |
| 2002-12-31 | CN¥0.61 | CN¥2.37 | x |
| 2003-12-31 | CN¥0.63 | CN¥2.37 | x |
| 2004-12-31 | CN¥0.65 | CN¥2.37 | x |
| 2005-12-31 | CN¥0.61 | CN¥2.37 | x |
| 2006-12-31 | CN¥0.49 | CN¥2.37 | x |
| 2007-12-31 | CN¥0.49 | CN¥2.37 | x |
| 2008-12-31 | CN¥0.41 | CN¥2.37 | x |
| 2009-12-31 | CN¥0.63 | CN¥2.37 | x |
| 2010-12-31 | CN¥0.71 | CN¥2.37 | x |
| 2011-12-31 | CN¥0.89 | CN¥2.37 | x |
| 2012-12-31 | CN¥0.94 | CN¥2.37 | x |
| 2013-12-31 | CN¥1.00 | CN¥2.37 | x |
| 2014-12-31 | CN¥2.32 | CN¥2.37 | x |
| 2015-12-31 | CN¥1.72 | CN¥2.37 | x |
| 2016-12-31 | CN¥3.24 | CN¥2.37 | x |
| 2017-12-31 | CN¥3.01 | CN¥2.37 | x |
| 2018-12-31 | CN¥2.03 | CN¥2.37 | x |
| 2019-12-31 | CN¥1.90 | CN¥2.37 | x |
| 2020-12-31 | CN¥1.89 | CN¥2.37 | x |
| 2021-12-31 | CN¥1.80 | CN¥2.37 | x |
| 2022-12-31 | CN¥1.40 | CN¥2.37 | x |
| 2023-12-31 | CN¥1.23 | CN¥2.37 | x |
| 2024-12-31 | CN¥0.89 | CN¥2.37 | x |
| 2025-12-31 | CN¥0.82 | CN¥2.37 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhongzhu Medical Holdings Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -19.78%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.21x
- Recent ROE (-6.98%) is below the historical average (-1.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 16.29% | 17.17% | 0.53x | 1.78x | CN¥3.69 Million |
| 1999 | 15.88% | 17.64% | 0.55x | 1.64x | CN¥4.10 Million |
| 2000 | 15.31% | 16.53% | 0.57x | 1.63x | CN¥4.37 Million |
| 2001 | 3.20% | 16.98% | 0.18x | 1.06x | CN¥-29.48 Million |
| 2002 | 2.52% | 12.33% | 0.19x | 1.08x | CN¥-33.28 Million |
| 2003 | 2.53% | 6.47% | 0.31x | 1.25x | CN¥-34.07 Million |
| 2004 | 1.85% | 1.94% | 0.59x | 1.63x | CN¥-38.62 Million |
| 2005 | -8.54% | -4.68% | 0.59x | 3.11x | CN¥-82.33 Million |
| 2006 | -24.30% | -5.85% | 1.13x | 3.67x | CN¥-122.27 Million |
| 2007 | 5.01% | 0.99% | 1.40x | 3.61x | CN¥-18.38 Million |
| 2008 | 9.90% | 1.65% | 1.49x | 4.01x | CN¥-422.47K |
| 2009 | 22.78% | 7.25% | 1.41x | 2.23x | CN¥82.22 Million |
| 2010 | 10.12% | 16.40% | 0.21x | 2.91x | CN¥877.83K |
| 2011 | 20.07% | 39.44% | 0.22x | 2.30x | CN¥91.86 Million |
| 2012 | 6.22% | 9.59% | 0.28x | 2.33x | CN¥-36.57 Million |
| 2013 | 5.88% | 7.67% | 0.30x | 2.56x | CN¥-42.42 Million |
| 2014 | 1.36% | 3.03% | 0.24x | 1.91x | CN¥-205.02 Million |
| 2015 | 3.01% | 7.96% | 0.21x | 1.76x | CN¥-170.34 Million |
| 2016 | 5.02% | 26.77% | 0.15x | 1.22x | CN¥-291.74 Million |
| 2017 | 2.83% | 17.26% | 0.13x | 1.21x | CN¥-429.55 Million |
| 2018 | -46.73% | -330.73% | 0.10x | 1.39x | CN¥-2.30 Billion |
| 2019 | -10.02% | -53.08% | 0.15x | 1.30x | CN¥-738.09 Million |
| 2020 | 0.08% | 0.44% | 0.16x | 1.19x | CN¥-376.39 Million |
| 2021 | -5.87% | -36.36% | 0.13x | 1.24x | CN¥-571.03 Million |
| 2022 | -28.57% | -157.97% | 0.14x | 1.33x | CN¥-1.08 Billion |
| 2023 | -14.02% | -53.86% | 0.21x | 1.23x | CN¥-589.34 Million |
| 2024 | -35.46% | -118.96% | 0.25x | 1.21x | CN¥-795.15 Million |
| 2025 | -6.98% | -19.78% | 0.29x | 1.21x | CN¥-277.79 Million |
Industry Comparison
This section compares Zhongzhu Medical Holdings Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $4,041,443,343
- Average return on equity (ROE) among peers: 10.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhongzhu Medical Holdings Co Ltd (600568) | CN¥1.61 Billion | 16.29% | 0.21x | $691.14 Million |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $971.04 Million | 5.41% | 3.98x | $565.97 Million |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.33 Billion | 6.10% | 1.68x | $359.03 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $8.39 Billion | 22.09% | 0.19x | $4.30 Billion |
| Livzon Pharmaceutical Group Inc (000513) | $3.01 Billion | 11.93% | 0.53x | $2.52 Billion |
| Wedge Industrial Co Ltd (000534) | $1.15 Billion | 11.42% | 1.59x | $2.41 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $1.42 Billion | 23.64% | 1.01x | $12.64 Billion |
| Hainan Haiyao Co Ltd (000566) | $445.29 Million | 14.73% | 0.90x | $715.72 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $347.80 Million | 3.58% | 0.72x | $319.94 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $905.53 Million | 2.15% | 1.95x | $916.75 Million |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $22.44 Billion | 6.25% | 0.15x | $3.00 Billion |
About Zhongzhu Medical Holdings Co Ltd
Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzone Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in produc… Read more